Ratings by TD Cowen (Max Masucci)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/13/2024 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2024 | MaxCyte Inc. | MXCT | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2024 | Bruker | BRKR | Maintain | Hold (N/A) |
|
Details | ||
| 8/19/2024 | Personalis | PSNL | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2024 | Alpha Teknova Inc. | TKNO | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2024 | Bruker | BRKR | Maintain | Hold (N/A) |
|
Details | ||
| 7/10/2024 | Alpha Teknova Inc. | TKNO | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2024 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2024 | Bruker | BRKR | Maintain | Hold (N/A) |
|
Details | ||
| 11/8/2023 | Cytek Biosciences Inc | CTKB | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2023 | Quanterix Corp. | QTRX | Maintain | Hold (N/A) |
|
Details | ||
| 11/7/2023 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2023 | Bruker | BRKR | Maintain | Hold (N/A) |
|
Details | ||
| 10/20/2023 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2023 | Bruker | BRKR | Maintain | Hold (N/A) |
|
Details | ||
| 3/29/2023 | DermTech Inc. | DMTK | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2023 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2022 | Cytek Biosciences Inc | CTKB | Maintain | Buy (N/A) |
|
Details | ||
| 12/6/2022 | PerkinElmer | PKI | Upgrade | Buy (Hold) |
139.23 (115.24) |
-17.23% | Details | |
| 11/15/2022 | Sema4 Holdings Corp | SMFR | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2022 | Bruker | BRKR | Maintain | Hold (N/A) |
|
Details | ||
| 11/9/2022 | Quanterix Corp. | QTRX | Maintain | Hold (N/A) |
|
Details | ||
| 11/7/2022 | DermTech Inc. | DMTK | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2022 | Hologic | HOLX | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2022 | Alpha Teknova Inc. | TKNO | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2022 | Quanterix Corp. | QTRX | Downgrade | Hold (Buy) |
16.49 (3.10) |
-81.2% | Details | |
| 6/23/2022 | MaxCyte Inc. | MXCT | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2022 | Sema4 Holdings Corp | SMFR | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2022 | Quanterix Corp. | QTRX | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2022 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2022 | Natera | NTRA | Maintain | Buy (N/A) |
|
Details | ||
| 4/20/2022 | Biodesix | BDSX | New Coverage | Buy (N/A) |
1.40 (1.58) |
12.86% | Details | |
| 3/23/2022 | Exagen | XGN | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2022 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2022 | Natera | NTRA | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2022 | Hologic | HOLX | Maintain | Buy (N/A) |
|
Details | ||
| 11/29/2021 | Evotec | EVO | New Coverage | Buy (N/A) |
23.33 (2.72) |
-88.34% | Details | |
| 11/10/2021 | DermTech Inc. | DMTK | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2021 | Codexis, Inc. | CDXS | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2021 | Bruker | BRKR | Maintain | Hold (N/A) |
|
Details | ||
| 11/3/2021 | PerkinElmer | PKI | Maintain | Hold (N/A) |
|
Details | ||
| 11/2/2021 | IsoPlexis Corp | ISO | New Coverage | Buy (N/A) |
13.58 (0.76) |
-94.4% | Details | |
| 11/2/2021 | Nautilus Biotechnology | NAUT | New Coverage | Buy (N/A) |
5.44 (2.24) |
-58.82% | Details | |
| 10/15/2021 | Personalis | PSNL | New Coverage | Buy (N/A) |
20.07 (9.59) |
-52.22% | Details | |
| 10/15/2021 | PerkinElmer | PKI | New Coverage | Hold (N/A) |
168.00 (115.24) |
-31.4% | Details | |
| 10/15/2021 | Hologic | HOLX | New Coverage | Buy (N/A) |
70.16 (76.01) |
8.34% | Details | |
| 10/15/2021 | Guardant Health | GH | New Coverage | Buy (N/A) |
102.01 (131.62) |
29.03% | Details | |
| 10/15/2021 | Exagen | XGN | New Coverage | Buy (N/A) |
12.71 (4.67) |
-63.26% | Details | |
| 10/15/2021 | DermTech Inc. | DMTK | New Coverage | Buy (N/A) |
31.52 (0.09) |
-99.71% | Details | |
| 10/15/2021 | Cytek Biosciences Inc | CTKB | New Coverage | Buy (N/A) |
22.44 (3.79) |
-83.11% | Details | |
| 10/15/2021 | Codexis, Inc. | CDXS | New Coverage | Buy (N/A) |
30.18 (2.40) |
-92.05% | Details | |
| 10/15/2021 | Codex DNA Inc. | DNAY | New Coverage | Buy (N/A) |
10.79 (1.30) |
-87.95% | Details | |
| 10/15/2021 | Burning Rock Biotech Ltd. | BNR | New Coverage | Buy (N/A) |
16.12 (8.59) |
-46.71% | Details | |
| 10/15/2021 | Bruker | BRKR | New Coverage | Hold (N/A) |
74.85 (54.23) |
-27.55% | Details | |
| 10/15/2021 | BioLife Solutions | BLFS | New Coverage | Buy (N/A) |
38.87 (26.10) |
-32.85% | Details | |
| 10/15/2021 | Alpha Teknova Inc. | TKNO | New Coverage | Buy (N/A) |
26.04 (4.20) |
-83.87% | Details | |
| 10/15/2021 | Absci Corp. | ABSI | New Coverage | Hold (N/A) |
10.42 (6.80) |
-34.74% | Details | |
| 10/15/2021 | 908 Devices Inc. | MASS | New Coverage | Buy (N/A) |
32.69 (8.27) |
-74.7% | Details | |
| 10/15/2021 | Quanterix Corp. | QTRX | New Coverage | Buy (N/A) |
48.43 (3.10) |
-93.6% | Details | |
| 10/15/2021 | MaxCyte Inc. | MXCT | New Coverage | Buy (N/A) |
10.84 (1.12) |
-89.67% | Details | |
| 10/15/2021 | Natera | NTRA | New Coverage | Buy (N/A) |
110.85 (212.07) |
91.31% | Details | |
| 9/30/2021 | Sema4 Holdings Corp | SMFR | New Coverage | Buy (N/A) |
7.44 (0.31) |
-95.83% | Details | |
| 9/23/2021 | Quanterix Corp. | QTRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/24/2021 | MaxCyte Inc. | MXCT | New Coverage | Buy (N/A) |
14.34 (1.12) |
-92.19% | Details | |
| 8/9/2021 | Rapid Micro Biosystems Inc | RPID | New Coverage | Buy (N/A) |
23.35 (1.76) |
-92.46% | Details | |
| 7/20/2021 | Alpha Teknova Inc. | TKNO | New Coverage | Buy (N/A) |
18.06 (4.20) |
-76.74% | Details |
